G Medical Innovations Holdings Ltd
GMVDF
$0.0002
$0.000.00%
| 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | |
|---|---|---|---|---|---|
| Revenue | -10.91% | -19.45% | -26.74% | -13.94% | 1.24% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -10.91% | -19.45% | -26.74% | -13.94% | 1.24% |
| Cost of Revenue | 5.33% | 79.45% | 152.91% | 58.90% | -18.45% |
| Gross Profit | -48.05% | -198.02% | -295.07% | -201.37% | 126.24% |
| SG&A Expenses | 139.90% | 121.96% | 102.95% | 65.69% | 22.58% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 99.82% | 106.15% | 112.90% | 62.90% | 10.96% |
| Operating Income | -149.91% | -173.61% | -202.19% | -107.28% | -15.99% |
| Income Before Tax | 4.44% | -36.73% | -84.82% | -49.53% | -14.83% |
| Income Tax Expenses | 633.33% | 282.35% | 207.14% | 137.50% | 83.33% |
| Earnings from Continuing Operations | 4.31% | -36.93% | -85.15% | -49.77% | -14.97% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 236.15% | 171.94% | 115.54% | 49.67% | -14.47% |
| Net Income | 6.47% | -35.53% | -84.79% | -49.77% | -15.32% |
| EBIT | -149.91% | -173.61% | -202.19% | -107.28% | -15.99% |
| EBITDA | -168.40% | -197.34% | -237.59% | -131.69% | -26.07% |
| EPS Basic | 40.09% | 16.70% | -5.67% | 7.39% | 19.12% |
| Normalized Basic EPS | 40.79% | 5.23% | -37.89% | -19.04% | -2.61% |
| EPS Diluted | 40.09% | 16.70% | -5.67% | 7.39% | 19.12% |
| Normalized Diluted EPS | 40.79% | 5.23% | -37.89% | -19.04% | -2.61% |
| Average Basic Shares Outstanding | 122.16% | 101.89% | 73.96% | 57.75% | 39.69% |
| Average Diluted Shares Outstanding | 122.16% | 101.89% | 73.96% | 57.75% | 39.69% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
